Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous fentanyl dose to attenuate hemodynamic response to endotracheal intubation in hypertensive patients
TCTR20241008003Phase 3Unknown
- Sponsor
- Khon Kaen University
- Start
- Nov 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in hypertension (HTN), sponsored by Khon Kaen University. Status: unknown.
02
Drugs
fentanyl
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20241008003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241008003.